Single User License
INR 101235
Site License
INR 202470
Corporate User License
INR 303705

Service Tax Additional

select a format
Price

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Polyphor Ltd.-Product Pipeline Review-2015

Polyphor Ltd.-Product Pipeline Review-2015


  Request for Sample Report

Executive Summary

Polyphor Ltd.-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'Polyphor Ltd.-Product Pipeline Review-2015', provides an overview of the Polyphor Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Polyphor Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Polyphor Ltd. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Polyphor Ltd.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Polyphor Ltd.'s pipeline products

Reasons To Buy

Evaluate Polyphor Ltd.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Polyphor Ltd. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Polyphor Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Polyphor Ltd. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Polyphor Ltd.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Polyphor Ltd. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Polyphor Ltd. Snapshot 5

Polyphor Ltd. Overview 5

Key Information 5

Key Facts 5

Polyphor Ltd.-Research and Development Overview 6

Key Therapeutic Areas 6

Polyphor Ltd.-Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products-Monotherapy 10

Pipeline Products-Partnered Products 11

Partnered Products/Combination Treatment Modalities 12

Pipeline Products-Out-Licensed Products 13

Out-Licensed Products/Combination Treatment Modalities 14

Polyphor Ltd.-Pipeline Products Glance 15

Polyphor Ltd.-Clinical Stage Pipeline Products 15

Phase II Products/Combination Treatment Modalities 15

Phase I Products/Combination Treatment Modalities 16

Polyphor Ltd.-Early Stage Pipeline Products 17

Preclinical Products/Combination Treatment Modalities 17

Discovery Products/Combination Treatment Modalities 18

Polyphor Ltd.-Drug Profiles 19

POL-6326 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

POL-5551 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

POL-6014 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

POL-6926 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

POL-7080 Follow-On 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

POL-7085 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

Small Molecule for Undisclosed Indication 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

Small Molecules for Infectious Diseases 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

Synthetic Peptide to Agonize FPR1/2 for Infectious Disease and Immunology 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

Synthetic Peptide to Antagonize FPR1/2 for Infectious Disease and Immunology 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

Polyphor Ltd.-Pipeline Analysis 32

Polyphor Ltd.-Pipeline Products by Target 32

Polyphor Ltd.-Pipeline Products by Route of Administration 33

Polyphor Ltd.-Pipeline Products by Molecule Type 34

Polyphor Ltd.-Pipeline Products by Mechanism of Action 35

Polyphor Ltd.-Recent Pipeline Updates 36

Polyphor Ltd.-Dormant Projects 37

Polyphor Ltd.-Locations And Subsidiaries 38

Head Office 38

Appendix 39

Methodology 39

Coverage 39

Secondary Research 39

Primary Research 39

Expert Panel Validation 39

Contact Us 39

Disclaimer 40

List of Tables

Polyphor Ltd., Key Information 5

Polyphor Ltd., Key Facts 5

Polyphor Ltd.-Pipeline by Indication, 2015 8

Polyphor Ltd.-Pipeline by Stage of Development, 2015 9

Polyphor Ltd.-Monotherapy Products in Pipeline, 2015 10

Polyphor Ltd.-Partnered Products in Pipeline, 2015 11

Polyphor Ltd.-Partnered Products/ Combination Treatment Modalities, 2015 12

Polyphor Ltd.-Out-Licensed Products in Pipeline, 2015 13

Polyphor Ltd.-Out-Licensed Products/ Combination Treatment Modalities, 2015 14

Polyphor Ltd.-Phase II, 2015 15

Polyphor Ltd.-Phase I, 2015 16

Polyphor Ltd.-Preclinical, 2015 17

Polyphor Ltd.-Discovery, 2015 18

Polyphor Ltd.-Pipeline by Target, 2015 32

Polyphor Ltd.-Pipeline by Route of Administration, 2015 33

Polyphor Ltd.-Pipeline by Molecule Type, 2015 34

Polyphor Ltd.-Pipeline Products by Mechanism of Action, 2015 35

Polyphor Ltd.-Recent Pipeline Updates, 2015 36

Polyphor Ltd.-Dormant Developmental Projects,2015 37

List of Figures

Polyphor Ltd.-Pipeline by Top 10 Indication, 2015 7

Polyphor Ltd.-Pipeline by Stage of Development, 2015 9

Polyphor Ltd.-Monotherapy Products in Pipeline, 2015 10

Polyphor Ltd.-Pipeline by Top 10 Target, 2015 32

Polyphor Ltd.-Pipeline by Top 10 Route of Administration, 2015 33

Polyphor Ltd.-Pipeline by Top 10 Molecule Type, 2015 34

Polyphor Ltd.-Pipeline Products by Top 10 Mechanism of Action, 2015 35

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Polyphor Ltd.; Polyphor Ltd. - Key Therapeutics; Polyphor Ltd. - Pipeline Overview and Promising Molecules; Polyphor Ltd. - News; Polyphor Ltd. - Latest Updates; Polyphor Ltd. - Pipeline; Polyphor Ltd. - Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com